Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders

▤ Summary

Cipher Pharmaceuticals announced the results of its annual general meeting of shareholders. Shareholders approved all matters presented in the management information circular, including the election of all director nominees and the re-appointment of RSM Canada LLP as auditor. About 14.65 million shares, or 57.71% of the outstanding shares, were represented at the meeting. The company also reiterated its specialty pharmaceutical business model, which focuses on acquiring and commercializing products across North America and South America.

▦ Linked Companies